Companies / Merck & Co., Inc. / Activity
Activity — Merck & Co., Inc.
56 moves.
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Feb 9, 2026 | Zachary Jennifer Executive | Sell | Common Stock | $6.77M | -57K -45.18% | 68,916 <0.01% of shares | medium |
| Feb 9, 2026 | Zachary Jennifer Executive | Exercise | Common Stock | $6.77M | +57K +82.41% | 125,708 <0.01% of shares | low |
| Jan 26, 2026 | Davis Robert M CEO | Grant | Common Stock | $5.09M | +47K +10.69% | 491,036 0.02% of shares | low |
| Feb 4, 2026 | Litchfield Caroline Executive | Sell | Common Stock | $5.02M | -42K -31.77% | 90,192 <0.01% of shares | medium |
| Feb 9, 2026 | Zachary Jennifer Executive | Sell | Common Stock | $4.63M | -39K -36.04% | 68,916 <0.01% of shares | medium |
| Feb 9, 2026 | Zachary Jennifer Executive | Exercise | Common Stock | $4.63M | +39K +56.35% | 107,751 <0.01% of shares | low |
| Feb 6, 2026 | DeLuca Richard R. Executive | Sell | Common Stock | $4.56M | -38K -19.05% | 160,174 <0.01% of shares | medium |
| Feb 4, 2026 | Davis Robert M CEO | Sell | Common Stock | $3.84M | -32K -6.82% | 443,602 0.02% of shares | medium |
| Feb 9, 2026 | Zachary Jennifer Executive | Sell | Common Stock | $3.09M | -26K -27.35% | 68,916 <0.01% of shares | medium |
| Feb 9, 2026 | Zachary Jennifer Executive | Exercise | Common Stock | $3.09M | +26K +37.65% | 94,862 <0.01% of shares | low |
| Feb 5, 2026 | Guindo Chirfi Executive | Sell | Common Stock | $2.44M | -20K -19.88% | 80,615 <0.01% of shares | medium |
| Feb 4, 2026 | Litchfield Caroline Executive | Exercise | Common Stock | $2.23M | +42K +46.56% | 132,189 <0.01% of shares | low |
| Jan 26, 2026 | Li Dean Y Executive | Grant | Common Stock | $2.20M | +20K +25.02% | 102,270 <0.01% of shares | low |
| Feb 6, 2026 | Oosthuizen Johannes Jacobus Executive | Sell | Common Stock | $1.83M | -15K -41.44% | 21,197 <0.01% of shares | medium |
| Feb 4, 2026 | Li Dean Y Executive | Sell | Common Stock | $1.79M | -15K -12.86% | 102,270 <0.01% of shares | medium |
| Feb 4, 2026 | Davis Robert M CEO | Sell | Common Stock | $1.76M | -15K -3.05% | 476,064 0.02% of shares | medium |
| Jan 26, 2026 | Litchfield Caroline Executive | Grant | Common Stock | $1.70M | +16K +21.32% | 90,192 <0.01% of shares | low |
| Jan 26, 2026 | Chattopadhyay Sanat Executive | Grant | Common Stock | $1.49M | +14K | 13,880 <0.01% of shares | low |
| Apr 29, 2026 | Davis Robert M CEO | Exercise | Common Stock | $1.46M | +13K +3.00% | 456,902 0.02% of shares | low |
| Jan 26, 2026 | DeLuca Richard R. Executive | Grant | Common Stock | $1.32M | +12K +6.61% | 197,859 <0.01% of shares | low |
| Jan 26, 2026 | Zachary Jennifer Executive | Grant | Common Stock | $1.24M | +12K +20.20% | 68,916 <0.01% of shares | low |
| Feb 12, 2026 | Guindo Chirfi Executive | Sell | Common Stock | $1.21M | -10K -14.16% | 60,615 <0.01% of shares | medium |
| Feb 10, 2026 | Li Dean Y Executive | Sell | Common Stock | $1.20M | -10K -10.01% | 92,035 <0.01% of shares | medium |
| Feb 9, 2026 | Guindo Chirfi Executive | Sell | Common Stock | $1.18M | -10K -12.40% | 70,615 <0.01% of shares | medium |
| Jan 26, 2026 | Guindo Chirfi Executive | Grant | Common Stock | $1.06M | +10K +10.87% | 100,615 <0.01% of shares | low |
| Feb 4, 2026 | Li Dean Y Executive | Exercise | Common Stock | $845.5K | +15K +14.75% | 117,357 <0.01% of shares | low |
| Apr 29, 2026 | Davis Robert M CEO | Other | Common Stock | $720.8K | -7K -1.43% | 450,351 0.02% of shares | low |
| Jan 26, 2026 | Williams David Michael Executive | Grant | Common Stock | $656.4K | +6K +24.72% | 30,838 <0.01% of shares | low |
| Jan 26, 2026 | Romanelli Joseph Executive | Grant | Common Stock | $612.5K | +6K +24.76% | 28,739 <0.01% of shares | low |
| Feb 6, 2026 | Williams David Michael Executive | Sell | Common Stock | $609.5K | -5K -13.95% | 30,838 <0.01% of shares | medium |
| Jan 26, 2026 | Oosthuizen Johannes Jacobus Executive | Grant | Common Stock | $539.8K | +5K +16.12% | 36,197 <0.01% of shares | low |
| Feb 4, 2026 | Smart Dalton E. III Executive | Sell | Common Stock | $478.7K | -4K -27.39% | 10,605 <0.01% of shares | medium |
| Feb 6, 2026 | Williams David Michael Executive | Exercise | Common Stock | $388.1K | +5K +16.21% | 35,838 <0.01% of shares | low |
| Feb 4, 2026 | Smart Dalton E. III Executive | Sell | Common Stock | $287.2K | -2K -22.63% | 8,205 <0.01% of shares | medium |
| Feb 4, 2026 | Smart Dalton E. III Executive | Exercise | Common Stock | $248.3K | +4K +37.72% | 14,605 <0.01% of shares | low |
| Jan 26, 2026 | Smart Dalton E. III Executive | Grant | Common Stock | $114.5K | +1K +11.18% | 10,605 <0.01% of shares | low |
| May 5, 2026 | Davis Robert M CEO | Grant | Stock Option (Right to Buy) | — | +140K | 139,697 <0.01% of shares | low |
| May 5, 2026 | Davis Robert M CEO | Grant | Restricted Stock Unit | — | +48K | 47,724 <0.01% of shares | low |
| Apr 29, 2026 | Davis Robert M CEO | Exercise | Restricted Stock Unit | — | -13K -33.33% | 26,601 <0.01% of shares | low |
| May 29, 2026 | Thulin Inge G Director | Grant | Phantom Stock | — | +2K +7.23% | 27,470 <0.01% of shares | low |
| May 29, 2026 | Craig Pamela J. Director | Grant | Phantom Stock | — | +2K +5.60% | 34,945 <0.01% of shares | low |
| May 29, 2026 | Baker Douglas M Jr Director | Grant | Phantom Stock | — | +2K +19.17% | 11,518 <0.01% of shares | low |
| May 29, 2026 | Glocer Thomas H Director | Grant | Phantom Stock | — | +2K +1.70% | 110,912 <0.01% of shares | low |
| Mar 31, 2026 | Glocer Thomas H Director | Grant | Phantom Stock | — | +405 +0.38% | 108,293 <0.01% of shares | low |
| May 29, 2026 | Lavizzo-Mourey Risa J Director | Grant | Phantom Stock | — | +2K +11.66% | 17,749 <0.01% of shares | low |
| May 29, 2026 | Russo Patricia F Director | Grant | Phantom Stock | — | +2K +3.06% | 62,391 <0.01% of shares | low |
| Feb 4, 2026 | Smart Dalton E. III Executive | Exercise | Stock Option (Right to Buy) | — | -4K -32.98% | 8,130 <0.01% of shares | low |
| Feb 4, 2026 | Litchfield Caroline Executive | Exercise | Stock Option (Right to Buy) | — | -42K -100.00% | 0 0.00% of shares | low |
| Feb 4, 2026 | Li Dean Y Executive | Exercise | Stock Option (Right to Buy) | — | -15K -100.00% | 0 0.00% of shares | low |
| Feb 6, 2026 | Williams David Michael Executive | Exercise | Stock Option (Right to Buy) | — | -5K -52.08% | 4,600 <0.01% of shares | low |